* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
None
Delistings:
None
What’s baking in the oven?
Potential IPOs:***
3 June: Reveille Resources has announced its intention to IPO onto AQSE. The strategy is focused on identifying and advancing uranium exploration opportunities in assets that have benefited from significant historical expenditure and technical work, but which may not have achieved full value realisation due to geopolitical, technological, financial, or historical factors. Reveille’s initial focus is on two historical uranium deposits in Lombardy, northern Italy. Pre-admission, Andrea Cattaneo, Ippolito Cattaneo, Ajax Resources PLC, and Zenith Energy Ltd. each hold 25% of the shares. The four pre-admission shareholders will be subject to a one-year lock-in and a subsequent one-year orderly market agreement. Expected Admission date is 2 July.
Banquet Buffet****
London Stock Exchange: Main Market and AIM
Aterian 24.50p £4.68m (ATN.L)
The critical minerals exploration and development Company announced that field operations have commenced under its recently established strategic joint venture with Lithosquare, marking the transition from partnership formation to active exploration across the Company's priority projects in Morocco and Botswana. The programmes combine advanced exploration technologies, including hyperspectral satellite imagery, artificial intelligence-driven target generation, geophysics, geochemistry and drilling to prioritise the Company's highest-potential projects while building a pipeline of future drilling opportunities. The programmes have been established and optimised based on Lithosquare's Geology AI.
Carclo 28.0p £24.96m (CAR.L)
The global precision engineering group with comprehensive, end-to-end manufacturing capabilities reports FY results to end March 2026. Revenue is £114.2m down from £121.2m in the prior period. The underlying operating profit increased 28.1% to £12.6m driven by operational efficiencies and a focus on higher margin business to give an EPS of 3.7p, which is up from 1.2p in the prior period. Net debt however increased 24.5% to £23.9m largely driven by a one-off additional pension contribution of £5.1m in April 2025. A Precision 2030 growth plan has been communicated and the success of these efforts can be seen through the delivery of the Group's financial targets ahead of schedule.
Clean Power Hydrogen 13.6p £68.27m (CPH2.L)
The UK-based green hydrogen technology Company has announced a fundraise including a Firm Placing and Subscription of £2.5m gross proceeds and a further Placing, Subscription and Retail Offer of up to £7.5m gross proceeds, subject to a general meeting at an issue price of 1.5p per share. The Company also announced its results for the year ended 31 December 2025 this morning: a Loss of £7.1m, cash and cash equivalents of £4.0m, successful fundraises completed receiving £13.7m gross proceeds during FY25 and £1.0m spent on development work in the period.
Croma Security Solutions Group 68.50p £9.16m (CSSG.L)
The innovation and service-focused security solutions provider announced the receipt of £440,064 representing the final payment to complete the £6.5m disposal of Vigilant Security Limited, provider of professional security personnel in the UK and Ireland. On 6 June 2023, Croma announced the disposal of Vigilant to focus on its higher margin Croma Locksmiths and Croma Security Systems businesses.
DSW Capital 43.50p £10.68m (DSW.L)
The owner of the Dow Schofield Watts brand announced that it has provided equity funding of £360k to support the acquisition of Integer Advisory Limited by Dow Schofield Watts Business Planning LLP. The combination creates a strengthened advisory business, bringing together DSW BP's expertise in social housing and infrastructure with Integer's established reputation and specialist sector knowledge. The strengthened and enlarged business, operating as DSW Integer, will be well positioned to support public sector organisations, as the demand for advisory services grows in response to increased Government investment in infrastructure, housing and public service. DSW Capital will continue to receive licence fee income from the enlarged business and will also hold an equity interest in the business, through its membership in the LLP.
EnergyPathways 6.8p £17.06m (EPP.L)
The UK energy transition Company announced that following the award of a Gas Storage Licence for its MESH project, the Licence work programme has been launched, and a site survey is planned for Q3 2026. Formal acceptance of the North Sea Transition Authority's Licence offer marks a significant milestone in advancing the MESH Project. The Company has commenced the Licence work programme and is planning an extensive survey in the East Irish Sea that will provide data to develop both the environmental, geological and seabed aspects of MESH. The survey results will underpin regulatory, engineering and subsurface workstreams as the Company progresses towards the next phase of development.
Goldplat 16.75p £27.06m (GDP.L)
The mining services group, with international gold recovery operations located in South Africa and Ghana, servicing the African and South American Mining Industry, announced a positive trading update for the current financial year ending 30 June 2026. As a result of the continued high gold prices and strong volumes, and subject to a number of year-end adjustments, the Board expects that the results for FY2026 will materially exceed prevailing market expectations.
Medpal AI 4.2p £24.64m (MPAL.L)
The AI-powered integrated digital health and pharmacy group announced the opening of its new robotic pharmacy dispensing and distribution facility at Sarus Court, Runcorn together with receipt of NHS approval for the new location. Sarus Court will be the Company's largest pharmacy robotic distribution facility to date and is expected to provide approximately 23,000 sqft of operational capacity when fully completed. It will replace the existing pharmacy distribution facility in Runcorn, as set out in the Company's announcement of 29 April 2026, and operate in addition to the Company's facility in Swaffham. The facility is being commissioned in phases and will, from this month, process more than 2,000 prescription items per day, with infrastructure designed to support throughput of over 10,000 prescription items per day once fully completed and operational.
Shearwater Group 43.50p £8.82m (SWG.L)
The cybersecurity, advisory, and managed security services Group, announced that Brookcourt Solutions, part of the Shearwater Group plc, has secured a five-year contract expansion valued at approximately £25m with a leading UK-based global telecommunications provider. The agreement extends and expands the long-standing relationship between Brookcourt and its valued customer and will see the continued delivery of the Company's packet monitoring, forensic analysis and service assurance solution across the provider's network infrastructure and key strategic clients.
Time Out Group 7.38p £37.89m (TMO.L)
The global media and hospitality business today announces that it has entered into a new 10-year franchise agreement with ITP Media Group covering Time Out's Media operations in Hong Kong and Singapore. Under the agreement, ITP will operate Time Out Hong Kong and Time Out Singapore, including their editorial operations, digital platforms, social channels, events and experiential activations. The agreement builds on a successful partnership spanning more than 20 years, during which ITP has operated Time Out franchises across the Gulf Cooperation Council, including Dubai, Abu Dhabi, Bahrain, Doha, Riyadh and Jeddah. ITP Media Group is a media company operating more than 40 brands and over 200 live events annually, reaching a global monthly audience of more than 200m across digital, social, print and live platforms.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
